pubmed-article:19131818 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19131818 | lifeskim:mentions | umls-concept:C0031001 | lld:lifeskim |
pubmed-article:19131818 | lifeskim:mentions | umls-concept:C0228174 | lld:lifeskim |
pubmed-article:19131818 | lifeskim:mentions | umls-concept:C0876926 | lld:lifeskim |
pubmed-article:19131818 | lifeskim:mentions | umls-concept:C0033497 | lld:lifeskim |
pubmed-article:19131818 | lifeskim:mentions | umls-concept:C0242184 | lld:lifeskim |
pubmed-article:19131818 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:19131818 | lifeskim:mentions | umls-concept:C1515655 | lld:lifeskim |
pubmed-article:19131818 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:19131818 | pubmed:dateCreated | 2009-1-9 | lld:pubmed |
pubmed-article:19131818 | pubmed:abstractText | Recent epidemiologic evidence has identified beta-blockade as independently associated with improved survival in patients with isolated traumatic brain injury (TBI). Reduced sympathetic discharge and catecholamine release may improve circulation in the injured areas and influence delayed demise. The purpose of this study was to investigate the cerebral effect of beta-blockade in a murine TBI model using immunohistochemical and microPET analysis. | lld:pubmed |
pubmed-article:19131818 | pubmed:language | eng | lld:pubmed |
pubmed-article:19131818 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19131818 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:19131818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19131818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19131818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19131818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19131818 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19131818 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19131818 | pubmed:month | Jan | lld:pubmed |
pubmed-article:19131818 | pubmed:issn | 1529-8809 | lld:pubmed |
pubmed-article:19131818 | pubmed:author | pubmed-author:SarinR CRC | lld:pubmed |
pubmed-article:19131818 | pubmed:author | pubmed-author:MarguliesDani... | lld:pubmed |
pubmed-article:19131818 | pubmed:author | pubmed-author:ContiPeter... | lld:pubmed |
pubmed-article:19131818 | pubmed:author | pubmed-author:ParkRyanR | lld:pubmed |
pubmed-article:19131818 | pubmed:author | pubmed-author:LeyEric JEJ | lld:pubmed |
pubmed-article:19131818 | pubmed:author | pubmed-author:ScehnetJeffJ | lld:pubmed |
pubmed-article:19131818 | pubmed:author | pubmed-author:SchroffStuS | lld:pubmed |
pubmed-article:19131818 | pubmed:author | pubmed-author:DagliyanGrant... | lld:pubmed |
pubmed-article:19131818 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19131818 | pubmed:volume | 66 | lld:pubmed |
pubmed-article:19131818 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19131818 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19131818 | pubmed:pagination | 154-9; discussion 159-61 | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:meshHeading | pubmed-meshheading:19131818... | lld:pubmed |
pubmed-article:19131818 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19131818 | pubmed:articleTitle | The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. | lld:pubmed |
pubmed-article:19131818 | pubmed:affiliation | Department of Surgery, Division of Trauma and Critical Care, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. | lld:pubmed |
pubmed-article:19131818 | pubmed:publicationType | Journal Article | lld:pubmed |